CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities
Net income	$ 115,379	$ 85,531
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	6,263	5,175
Deferred income taxes	0	204
Stock-based compensation, net of amounts capitalized	51,339	34,958
Non-cash lease expense	904	951
Accretion of discount on marketable securities, net	(4,687)	(5,368)
Amortization of deferred contract costs	6,772	4,759
Impairment of long-lived assets	0	2,304
Other	(114)	(122)
Changes in operating assets and liabilities:
Accounts receivable	(985)	(23,478)
Prepaid expenses and other assets	3,451	19,948
Deferred contract costs	(4,549)	(3,216)
Accounts payable, accrued expenses and other liabilities	(2,333)	(5,546)
Deferred revenue	(14,268)	(5,457)
Operating lease liabilities	(1,127)	(1,054)
Net cash provided by operating activities	156,045	109,589
Cash flows from investing activities
Cash paid for acquisition, net of cash acquired	(26,528)	0
Internal-use software development costs	(4,335)	(3,247)
Purchases of marketable securities	(268,200)	(367,808)
Maturities of marketable securities	270,031	417,913
Sales of marketable securities	0	7,241
Net cash provided by (used in) investing activities	(29,032)	54,099
Cash flows from financing activities
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants	4,796	10,243
Proceeds from issuance of common stock in connection with the employee stock purchase plan	1,816	1,422
Taxes paid related to net share settlement of equity awards	(24,493)	(8,222)
Repurchase of common stock	(144,248)	(74,198)
Payment of contingent consideration related to a business combination	(5,249)	(5,470)
Net cash used in financing activities	(167,378)	(76,225)
Net increase (decrease) in cash and cash equivalents	(40,365)	87,463
Cash and cash equivalents, beginning of period	209,614	96,785
Cash and cash equivalents, end of period	169,249	184,248
Supplemental disclosures of cash flow information
Cash paid for taxes, net of refunds	19,347	21,985
Non-cash financing and investing activities
Equity awards included in purchase consideration	$ 9,550	$ 0

Increase (Decrease) In Capitalized Contract Cost

No definition available.

Name:	docs_IncreaseDecreaseInCapitalizedContractCost
Namespace Prefix:	docs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.